Pacer Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7K Buy
1,214
+450
+59% +$3.39K ﹤0.01% 2191
2025
Q4
$5.48K Sell
764
-456
-37% -$3.6K ﹤0.01% 3681
2025
Q3
$13K Buy
+1,220
New +$12K ﹤0.01% 3719
2025
Q1
Sell
-11,152,179
Closed -$166M 3740
2024
Q4
$166M Buy
11,152,179
+11,140,388
+94,482% +$182M 0.36% 72
2024
Q3
$226K Buy
11,791
+11,441
+3,269% +$237K ﹤0.01% 1839
2024
Q2
$7.25K Buy
350
+48
+16% +$954 ﹤0.01% 3596
2024
Q1
$5.68K Hold
302
﹤0.01% 3587
2023
Q4
$4.36K Sell
302
-48,977
-99% -$666K ﹤0.01% 3435
2023
Q3
$855K Buy
49,279
+8,896
+22% +$185K ﹤0.01% 930
2023
Q2
$840K Buy
40,383
+24,523
+155% +$533K ﹤0.01% 1215
2023
Q1
$373K Buy
15,860
+14,613
+1,172% +$392K ﹤0.01% 1217
2022
Q4
$34.8K Sell
1,247
-30,634
-96% -$783K ﹤0.01% 2965
2022
Q3
$746K Sell
31,881
-1,410,577
-98% -$42.6M 0.01% 626
2022
Q2
$48.7M Buy
1,442,458
+336,543
+30% +$11.8M 0.36% 60
2022
Q1
$38.6M Buy
1,105,915
+609,062
+123% +$20.8M 0.32% 71
2021
Q4
$15.1M Buy
496,853
+198,413
+66% +$6.46M 0.16% 110
2021
Q3
$9.79M Buy
298,440
+264,653
+783% +$8.47M 0.12% 204
2021
Q2
$1.02M Buy
+33,787
New +$1.11M 0.01% 839

Other funds holding OGN

Pacer Advisors's OGN Position: Q1 2026 in Review

Pacer Advisors increased its Organon & Co (OGN) stake by 59% in Q1 2026, buying an estimated $3.39K and bringing the position to 1,214 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #2191.

Pacer Advisors first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $166M in Q4 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Pacer Advisors held 1,214 shares of Organon & Co worth $7K as of Q1 2026.
  • Pacer Advisors bought 450 Organon & Co shares in Q1 2026, an estimated $3.39K.
  • Organon & Co made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #2191 holding.
  • Pacer Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
  • Pacer Advisors's Organon & Co position peaked at $166M in Q4 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.